Rocket Lab Stock: Bull vs. Bear

Rocket Lab reported Q2 2026 revenue of $234 million (+62% YoY) and grew backlog 137% YoY to a record $2.36B, guiding Q3 revenue of $250M–$265M. However, Neutron’s launch was pushed back to Q4 2026 at the earliest after a January tank rupture, while the company remains unprofitable with a $49M net loss in Q2 and trades at ~51x trailing sales (high valuation). The new $266M multi-launch and $397M Flatellite contracts for the U.S. Space Force are supportive, but valuation and Neutron delay keep the setup divisive for investors.

Analysis

RKLB is still being priced like a pre-profit platform story, but the market is increasingly forcing it to prove hardware execution before granting any more multiple expansion. The key issue is that backlog and contract wins do not solve the schedule-risk problem: if the launch system slips, fixed engineering spend keeps compounding while the promised operating leverage gets pushed out, which is exactly when high-multiple names de-rate fastest.

Near term, the stock is likely to trade on sentiment and milestone headlines, not on fundamentals; that creates asymmetric downside if the next hardware update disappoints. Over 1-3 months, the biggest risk is a second delay that opens the door to a 2027 narrative and raises the probability of equity issuance before any EBITDA inflection. Over 6-18 months, the thesis becomes much more durable only if the company proves it can move from one-off contract momentum to repeatable, capital-efficient flight economics.

The consensus appears to underweight how much of the valuation is effectively an option on flawless execution. That makes this less attractive as an outright long today and more interesting as a relative-value short against cleaner space-defense exposure. The thesis is falsified if Neutron achieves a clean first flight on schedule and management keeps the path to breakeven intact without incremental dilution.

Key Decisions for Investors

• Do not chase RKLB on contract-driven strength; wait for a confirmed Neutron flight milestone before adding exposure. Risk/reward is poor until hardware de-risks, because the stock is already discounting a best-case execution path.
• If you want to express a bearish view, use a 1-3 month RKLB put spread on any rally into launch headlines. Falsifier: a successful Neutron test/flight announcement that preserves the 2026 window.
• Relative-value pair: long LHX or XAR vs short RKLB for 1-3 months. The idea is that capital should rotate toward more established space-defense cash flows if launch timing risk remains unresolved.
• For investors who need upside exposure, prefer a small, defined-risk 6-12 month call spread only after the first clean Neutron validation. Before that, dilution and delay risk make outright longs unattractive.
• Set a watch item for any update implying 2027 slip or new capital needs; either would likely trigger a sharp multiple reset and should be treated as a tactical exit signal.